Kimberly R. Kalli

Folate receptor alpha as a tumor target in epithelial ovarian cancer

Kimberly R. Kalli, Ann L. Oberg, Gary L. Keeney et al. · Gynecologic Oncology · 2008 · 447 citations · Full text

Epithelial Ovarian Cancer, Medicine, Folate Receptor Alpha +9

Hormone-receptor expression and ovarian cancer survival: an Ovarian Tumor Tissue Analysis consortium study

Weiva Sieh, Martin Köbel, Teri A. Longacre et al. · The Lancet Oncology · 2013 · 423 citations · Full text

Ovarian Cancer Survival, Medicine, Hormonal Receptor +8

Prognostic and Therapeutic Relevance of Molecular Subtypes in High-Grade Serous Ovarian Cancer

Gottfried E. Konecny, Chen Wang, Habib Hamidi et al. · JNCI Journal of the National Cancer Institute · 2014 · 397 citations · Full text

Transcriptional Profiling, Molecular Subtypes, Therapeutic Relevance +12

Dose-Response Association of CD8⁺ Tumor-Infiltrating Lymphocytes and Survival Time in High-Grade Serous Ovarian Cancer

Ellen L. Goode, Matthew S. Block, Kimberly R. Kalli et al. · JAMA Oncology · 2017 · 388 citations · Full text

Immune-Induced Epithelial to Mesenchymal Transition <i>In vivo</i> Generates Breast Cancer Stem Cells

Marta Santisteban, Jennifer M. Reiman, Michael K. Asiedu et al. · Cancer Research · 2009 · 378 citations · Full text

Breast Oncology, Adult Stem Cell, Immunology +18